SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biogen
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
1686 75 0 BIIB
Emcee:  Harold Engstrom Type:  Unmoderated
Introduction Market Data Compact
Biogen-Idec as a combined company is a good, solid operating company. They have slowing sales however and, aside from Antegren (50% owned by Elan) not much of a pipeline.

Will be interesting to see how the supposed synergies from merger between Biogen and Idec play out.

Anyone have any ideas about this company?
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1686Updated 7:50 PM Re: BIIB Researchers released new details from a study of a cSr K-11/29/2022
1685Biogen, Eisai drive rally in Alzheimer’s stocks as lecanemab succeeds in late-stJulius Wong-9/28/2022
1684Biogen And Eisai Rewrite Alzheimer’s Drug Marketing Pact Eisai is giving up itsSr K-3/14/2022
1683Medicare to Pay for Biogen’s New Alzheimer’s Drug in Clinical-Trial Patients ThSr K-1/11/2022
1682Third member of prestigious FDA panel resigns over approval of Biogen’s AlzheimeGlenn Petersen26/11/2021
1681Excerpt FDA Approves First New Alzheimer’s Drug in Nearly Two Decades Biogen dSr K16/7/2021
1680Biogen shares surge 60% after FDA approves Alzheimer’s drug, the first new theraGlenn Petersen16/7/2021
1679No posts since Dec 2016. Sanofi made an offer to buy Biogen spinoff BIVV, whicSr K-1/22/2018
1678BIIB Stock: Unexpected Sell-Off Biogen Inc (NASDAQ:BIIB) stock is down 5.91% on Issac-12/2/2016
1677Biogen and Ionis Pharmaceuticals Announce SPINRAZA (nusinersen) Meets Primary EnJulius Wong-11/7/2016
1676on Briefing.com Ionis Pharma (IONS 36.48, +7.29): +25.0% after Biogen (BIIB 302Sr K-8/1/2016
1675All-time high, 363.28 close 365.19 highSr K-1/20/2015
1674BIIB to be added to the S&P 100, after the close 3/21. finance.yahoo.comSr K-3/17/2014
1673SEOUL, Korea & WESTON, Mass.--(BUSINESS WIRE)-- Samsung and Biogen Idec (NAnigel bates-12/6/2011
1672Biogen MS trial data reveals no safety surprises Wed Oct 5, 2011 6:45am EDT mopgcw-10/5/2011
1671European Commission Approves Inclusion of Anti-JC Virus Antibody Status as a PMLsim1-6/22/2011
1670BG-12 met the primary and secondary endpoints in phase III DEFINE trial news-midos-4/11/2011
1669cs Biogen Idec (BIIB) NEUTRAL [V] R. Mehrotra CP: US$ 73.03 TP: US$ 69 CAP: US$ mopgcw-4/9/2011
1668cs: Biogen Idec (BIIB) NEUTRAL [V] Industry Weighting: OVERWEIGHT R. Mehrotra CPmopgcw-12/18/2010
1667>>Brain Infections From Biogen, Elan MS Drug Continue To Rise Last update:tuck-8/19/2010
1666Biogen Idec and Elan Enroll First Patient in Large, Well-Controlled Head-to-Headsim1-3/25/2010
1665Sure, yes. If they're into protein constructs and digging for leveraged invscaram(o)uche-3/11/2010
1664Sure, thanks, now I am blushing. But, can my rambling help anyone make any monePseudo Biologist-3/11/2010
1663<i>Very tricky business this one of making so-called "bio betters.&quscaram(o)uche-3/11/2010
1662We can start with the <i>what</i> As you may recall Rituxan is chimPseudo Biologist-3/11/2010
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2023 Knight Sac Media.  Data provided by IEX, Alpha Vantage, Coinbase, Binance, Fintel and CityFALCON News